PPD offers a broad range of early development services, Phase I clinical trial services and nonclinical consulting.
Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
Get information about PPD posted on industry websites and publications.
Within pharmacovigilance at PPD, we have implemented various artificial intelligence and machine learning methods that help us and our clients achieve better results.
Gary Barker, Denise Moody, Magda Santos and April Pierce provide insight into creating and keeping a successful pharmacovigilance partnership with a functional service provider.
Brian Brogan, senior logistics manager, provides guidance for clinical trial supply chain requirements post-Brexit and offers some practical solutions for affected U.K.-based life science companies.
Giovanni Monopoli, senior project manager, reflects on what he learned about the eligibility criteria at an American Society of Clinical Oncology (ASCO) conference presentation in 2017.
In the final of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.
We want to hear from you
Register in PPD's Database
© 2018 Pharmaceutical Product Development, LLC. All rights reserved.